Suchergebnisse - (Person:"Lu, Xinjie")

PubPharm (5)

1

Long-Term Efficacy and Safety of Immunomodulatory Therapy for Atherosclerosis

enthalten in: Cardiovascular drugs and therapy | 2019

von Thota, L. | Ponnusamy, T. | Lu, X. | +1

2

Immune regulation by oral tolerance induces alternate activation of macrophages and reduces markers of plaque destabilization in Apobtm2Sgy/Ldlrtm1Her/J mice

enthalten in: Scientific reports | 2017

von Thota, L. | Ponnusamy, T. | Philip, S. | +2

ErratumIn: Sci Rep. 2018 Oct 24;8(1):15974. - PMID 30356091

3

Modulation of recombinant antigenic constructs containing multi-epitopes towards effective reduction of atherosclerotic lesion in B6;129S-Ldlr(tm1Her)Apob(tm2Sgy)/J mice

enthalten in: PloS one | 2015

von Xia, M. | Chen, D. | Endresz, V. | +4

4

Impact of multiple antigenic epitopes from ApoB100, hHSP60 and Chlamydophila pneumoniae on atherosclerotic lesion development in Apob(tm2Sgy)Ldlr(tm1Her)J mice

enthalten in: Atherosclerosis | 2012

von Lu, X. | Xia, M. | Endresz, V. | +6

5

Immunization with a combination of ApoB and HSP60 epitopes significantly reduces early atherosclerotic lesion in Apobtm2SgyLdlrtm1Her/J mice

enthalten in: Atherosclerosis | 2010

von Lu, X. | Chen, D. | Endresz, V. | +8

1
[1]